DOI QR코드

DOI QR Code

Differential Expression of Cytokeratin 13 in Non-Neoplastic, Dysplastic and Neoplastic Oral Mucosa in a High Risk Pakistani Population

  • 발행 : 2015.08.03

초록

Background: Gradual loss of cytokeratin 13 (CK13) may be linked with the severity of dysplastic changes and transformation to malignancy. In this study we assessed the differential expression of CK13 in normal, hyperplastic, dysplastic and cancerous oral mucosa. Materials and Methods: A total of 93 oral biopsies were collected during the 2011-2014 period. The biopsies were characterized as normal (19), hyperplastic (21), severely dysplastic/carcinoma in situ (16) and invasive oral squamous cell carcinoma (OSCC) (37) after morphological assessment. Formalin fixed paraffin embedded sections were stained with a monoclonal antibody against CK13 using the Envision technique. Immunohistochemically stained slides were then analyzed for CK13 expression. Results: CK13 was consistently and diffusely expressed in all normal and hyperplastic tissue biopsies from oral mucosa. Severely dysplastic/carcinoma in situ biopsies showed complete loss in 50% of cases, while in the remaining 50% expression was very focal and weak. OSCC cases showed complete or near complete loss of CK13 in all cases. Few cases showed weak expression in keratin pearls only. Conclusions: This study validates the utility of CK13 IHC as a useful immunohistochemical marker in routine diagnostic practice to make distinction between non-neoplastic from dysplastic and neoplastic (malignant) oral lesions.

키워드

참고문헌

  1. Bhurgri Y, Bhurgri A, Hussainy AS, et al (2003). Cancer of the oral cavity and pharynx in Karachi--identification of potential risk factors. Asian Pac J Cancer Prev, 4, 125-30.
  2. Bhurgri Y (2005). Cancer of the oral cavity-trends in Karachi South (1995-2002). Asian Pac J Cancer Prev, 6, 22-6.
  3. Bhurgri Y (2007). Age standardized incidence of oral cancer rate per 100,000 in males of Karachi South. Unpublished data Karachi cancer registry.
  4. Challacombe S, Chidzonga M, Glick M. et al (2011). Global Oral Health Inequalities: Oral Infections-Challenges and Approaches. Adv Dent Research, 23, 207-10. https://doi.org/10.1177/0022034511402015
  5. David C, Mark P, Helen M, et al (2008). Socioeconomic inequalities and oral cancer risk: a systemic review and meta -analysis of case-control studies. Int J Cancer, 122, 2811-9. https://doi.org/10.1002/ijc.23430
  6. Firstine K, Lee P, Vui K, et al (2015). KRT13, FAIM2 and CYP2W1 mRNA expression in oral squamous cell carcinoma patients with risk habits. Asian Pac J Cancer Prev, 16, 953-8. https://doi.org/10.7314/APJCP.2015.16.3.953
  7. Hiroko I, Satoshi M, Takanori K, et al (2012). Loss of keratin 13 in oral carcinoma in situ: a comparative study of protein and gene expression levels using paraffin sections. Modern Pathology, 25, 784-94. https://doi.org/10.1038/modpathol.2011.218
  8. Itakura Y, Sasano H, Abe K, et al (1996). Cytokeratin immunolocalization and lectin binding studies in oesophageal squamous dysplasia. Histopathology, 29, 3-10. https://doi.org/10.1046/j.1365-2559.1996.d01-480.x
  9. Khandekar S, Bagdey P, Tiwari R, et al (2006). Oral cancer and some epidemiological factors: A hospital based study. Indian Journal of Community Medicine, 31, 157-9.
  10. Kitamura R, Toyoshima T, Tanaka H, et al (2012). Association of cytokeratin 17 expression with differentiation in oral squamous cell carcinoma. J Cancer Res Clin Oncol, 138, 1299-310. https://doi.org/10.1007/s00432-012-1202-6
  11. Kobayashi T, Maruyama S, Cheng J (2010). Histopathological varieties of oral carcinoma in situ: Diagnosis aided by immunohistochemistry dealing with the second basal as the proliferating centre of oral mucosal epithelia. Pathol Int, 60, 156-66. https://doi.org/10.1111/j.1440-1827.2009.02499.x
  12. Lallemant B, Evard A, Combescure C, et al (2009). The clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse. BMC Cancer, 9, 370. https://doi.org/10.1186/1471-2407-9-370
  13. Mikami T, Cheng J, Maruyama S, et al (2011). Emergence of keratin 17 versus loss of keratin 13: their reciprocal immunohistochemical profiles in oral carcinoma in situ. Oral Oncol, 47, 497-503. https://doi.org/10.1016/j.oraloncology.2011.03.015
  14. Moll R, Franke WW, Schiller DL, et al (1982). The catalog of human cytokeratins: patterns of expression in normal epithelia,tumors and cultured cells. Cell, 31, 11-24. https://doi.org/10.1016/0092-8674(82)90400-7
  15. Moll R (1998). Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. Subcell Biochem, 31, 205-62.
  16. Noguchi S, Sato K, Yamamoto G, et al (2011). Expression of cytokeratin 13 and 17 in tongue squamous cell carcinoma and epithelial dysplasia. Asian Journal of Oral and Maxillofacial Surgery, 23, 53-8. https://doi.org/10.1016/j.ajoms.2010.12.005
  17. Schaaij-Visser TB, Bremmer JF, Braakhuis BJ, et al (2010). Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia. Oral Oncol, 46, 123-7. https://doi.org/10.1016/j.oraloncology.2009.11.012
  18. van Bommel PF, Kenemans P, Helmerhorst TJ, et al (1994). Expression of cytokeratin 10, 13, and involucrin as prognostic factors in low stage squamous cell carcinoma of the uterine cervix. Cancer, 74, 2314-20. https://doi.org/10.1002/1097-0142(19941015)74:8<2314::AID-CNCR2820740816>3.0.CO;2-1
  19. Wake M (1993). The urban/rural divide in head and neck cancerthe effect of atmospheric pollution. Clin Otolaryngol Allied Sci, 18, 298-302. https://doi.org/10.1111/j.1365-2273.1993.tb00852.x
  20. Walsh T, Liu JL, Brocklehurst P, et al (2013). Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev, 11, 10173.
  21. Warnakulasuriya S, Johnson NW, van der Waal I (2007). Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med, 36, 575-80. https://doi.org/10.1111/j.1600-0714.2007.00582.x
  22. Warnakulasuriya S (2009). Global epidemiology of oral and oropharyngeal cancer. Oral Oncol, 45, 309-16. https://doi.org/10.1016/j.oraloncology.2008.06.002
  23. Yanagava T, Yoshida H, Yamagata K, et al (2007). Loss of cytokeratin 13 expression in squamous cell carcinoma of the tongue is a possible sign for local recurrence. J Exp Clin Cancer Res, 26, 215-20.

피인용 문헌

  1. KF-finder: identification of key factors from host-microbial networks in cervical cancer vol.12, pp.S4, 2018, https://doi.org/10.1186/s12918-018-0566-x
  2. Significance of immunohistochemical overexpression of cyclooxygenase-2 in overall and disease-free survival of oral squamous cell carcinoma patients vol.132, pp.12, 2018, https://doi.org/10.1017/S0022215118002207